paper: Arunachalam, P. S., Wimmers, F., Mok, C. K. P., Perera, R. A., Scott, M., Hagan, T., ... & Pulendran B. (2020). Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science, 369(6508), 1210-1220. Chicago
contributor: Bali Pulendran
contributor_organization: Stanford
contributor_email: bpulend@stanford.edu
-
- description: Genes differentially expressed in COVID-19 patients compared to healthy controls
- exact_source: Fig. 4, Table S4 Tab "DEG_healthy_vs_covid-19"
- tissue: PBMC
- immune_exposure: SARS-CoV-2 infection
- cohort: Adults (38 - 90)
- comparison: COVID-19 vs healthy
- repository_id: GSE155673
- platform: CITE-seq
- response_components:
- response_behavior: Up or down
-
- description: Interferon-stimulated genes in COVID-19 patients
- exact_source: Fig. 4G and supplementary fig. 15A
- tissue: PBMC
- immune_exposure: SARS-CoV-2 infection
- cohort: Adults (38 - 90)
- comparison: COVID-19 vs healthy
- repository_id: GSE152418
- platform: Bulk RNAseq
- response_components:
- response_behavior: Up
-
- description:
- exact_source:
- tissue:
- immune_exposure:
- cohort:
- comparison:
- repository_id:
- platform:
- response_components:
- response_behavior:
-
- description:
- exact_source:
- tissue:
- immune_exposure:
- cohort:
- comparison:
- repository_id:
- platform:
- response_components:
- response_behavior:
-
-
-
PMID
32788292
abstract
COVID-19 represents a global crisis, yet major knowledge gaps remain about human immunity to SARS-CoV-2. We analyzed immune responses in 76 COVID-19 patients and 69 healthy individuals from Hong Kong and Atlanta. In PBMCs of COVID-19 patients, there was reduced expression of HLA-DR and pro-inflammatory cytokines by myeloid cells, and impaired mTOR-signaling and IFN-α production by plasmacytoid DCs. In contrast, there were enhanced plasma levels of inflammatory mediators, including EN-RAGE, TNFSF14, and oncostatin-M, which correlated with disease severity and increased bacterial products in human plasma. Single-cell transcriptomics revealed no type-I IFN, reduced HLA-DR in myeloid cells of severe patients, and transient expression of IFN-stimulated genes. This was consistent with bulk PBMC transcriptomics, and transient, low plasma IFN-α levels during infection. These results reveal mechanisms and potential therapeutic targets for COVID-19.
status
review complete
curator
Kenneth Smith
reviewer
Aris Floratos
journal
Science
date curation completed
date review completed
edit spreadsheet url
view spreadsheet url
manuscript url
year of publication
2020
In Dashboard
Yes